|
Insmed Com Par $.01
(INSM)
|
8.2 |
$94M |
|
655k |
144.01 |
|
Verona Pharma Sponsored Ads
(VRNA)
|
5.8 |
$67M |
|
625k |
106.71 |
|
Spdr S&p 500 Etf Tr Tr Unit
(SPY)
|
4.9 |
$56M |
|
85k |
666.18 |
|
Xenon Pharmaceuticals
(XENE)
|
4.9 |
$56M |
|
1.4M |
40.15 |
|
Madrigal Pharmaceuticals
(MDGL)
|
4.6 |
$53M |
|
115k |
458.66 |
|
Apogee Therapeutics
(APGE)
|
4.1 |
$47M |
|
1.2M |
39.73 |
|
Arcellx Common Stock
(ACLX)
|
3.6 |
$41M |
|
500k |
82.10 |
|
Alkermes SHS
(ALKS)
|
3.3 |
$38M |
|
1.3M |
30.00 |
|
Nuvalent Inc-a
(NUVL)
|
2.9 |
$33M |
|
384k |
86.48 |
|
Abivax Sa Sponsored Ads
(ABVX)
|
2.7 |
$31M |
|
360k |
84.90 |
|
Mineralys Therapeutics
(MLYS)
|
2.5 |
$28M |
|
750k |
37.92 |
|
Teva Pharmaceutical Inds Sponsored Ads
(TEVA)
|
2.5 |
$28M |
|
1.4M |
20.20 |
|
Merus N V
(MRUS)
|
2.3 |
$27M |
|
286k |
94.15 |
|
Centessa Pharmaceuticals Sponsored Ads
(CNTA)
|
2.3 |
$27M |
|
1.1M |
24.25 |
|
Lexeo Therapeutics
(LXEO)
|
2.2 |
$26M |
|
3.9M |
6.64 |
|
Trevi Therapeutics
(TRVI)
|
2.2 |
$26M |
|
2.8M |
9.15 |
|
Spyre Therapeutics Com New
(SYRE)
|
2.1 |
$24M |
|
1.4M |
16.76 |
|
Exelixis Put Option
(EXEL)
|
1.8 |
$21M |
|
500k |
41.30 |
|
Rezolute Com New
(RZLT)
|
1.7 |
$20M |
|
2.1M |
9.40 |
|
Cytokinetics Com New
(CYTK)
|
1.7 |
$19M |
|
350k |
54.96 |
|
Oruka Therapeutics
(ORKA)
|
1.6 |
$18M |
|
959k |
19.23 |
|
Uniqure Nv SHS
(QURE)
|
1.5 |
$18M |
|
300k |
58.37 |
|
Wave Life Sciences SHS
(WVE)
|
1.3 |
$15M |
|
2.1M |
7.32 |
|
Protagonist Therapeutics
(PTGX)
|
1.3 |
$15M |
|
221k |
66.43 |
|
Soleno Therapeutics
(SLNO)
|
1.2 |
$14M |
|
200k |
67.60 |
|
Avalo Therapeutics Com New
(AVTX)
|
1.1 |
$13M |
|
1.0M |
12.71 |
|
Establishment Labs Holdings Ord
(ESTA)
|
1.1 |
$13M |
|
310k |
40.99 |
|
Karyopharm Therapeutics Note 3.000%10/1 (Principal)
|
1.1 |
$13M |
|
15M |
0.82 |
|
Ventyx Biosciences
(VTYX)
|
1.1 |
$12M |
|
3.9M |
3.11 |
|
Roivant Sciences SHS
(ROIV)
|
1.1 |
$12M |
|
800k |
15.13 |
|
Travere Therapeutics
(TVTX)
|
1.0 |
$12M |
|
500k |
23.90 |
|
Dianthus Therapeutics
(DNTH)
|
0.9 |
$10M |
|
262k |
39.35 |
|
Taysha Gene Therapies Com Shs
(TSHA)
|
0.9 |
$9.8M |
|
3.0M |
3.27 |
|
Erasca
(ERAS)
|
0.8 |
$9.3M |
|
4.3M |
2.18 |
|
Nurix Therapeutics
(NRIX)
|
0.8 |
$8.9M |
|
968k |
9.24 |
|
Vera Therapeutics Cl A
(VERA)
|
0.8 |
$8.8M |
|
303k |
29.06 |
|
Enliven Therapeutics
(ELVN)
|
0.7 |
$8.2M |
|
400k |
20.47 |
|
Travere Therapeutics Note 2.250% 3/0 (Principal)
|
0.7 |
$7.9M |
|
7.0M |
1.13 |
|
Newamsterdam Pharma Company Ordinary Shares
(NAMS)
|
0.7 |
$7.8M |
|
275k |
28.44 |
|
Celldex Therapeutics Com New
(CLDX)
|
0.7 |
$7.8M |
|
300k |
25.87 |
|
Proqr Thrapeutics N V Shs Euro
(PRQR)
|
0.7 |
$7.7M |
|
3.6M |
2.13 |
|
Tarsus Pharmaceuticals
(TARS)
|
0.6 |
$7.4M |
|
125k |
59.43 |
|
Summit Therapeutics Put Option
(SMMT)
|
0.6 |
$7.2M |
|
350k |
20.66 |
|
Akebia Therapeutics
(AKBA)
|
0.6 |
$6.7M |
|
2.5M |
2.73 |
|
Monopar Therapeutics Com New
(MNPR)
|
0.6 |
$6.5M |
|
80k |
81.67 |
|
Zura Bio Class A Ord Shs
(ZURA)
|
0.5 |
$5.5M |
|
1.3M |
4.33 |
|
Miragen Therapeutics
(VRDN)
|
0.5 |
$5.4M |
|
250k |
21.58 |
|
Savara
(SVRA)
|
0.5 |
$5.4M |
|
1.5M |
3.57 |
|
Intellia Therapeutics Call Option
(NTLA)
|
0.5 |
$5.2M |
|
300k |
17.27 |
|
Olema Pharmaceuticals
(OLMA)
|
0.4 |
$4.9M |
|
500k |
9.79 |
|
Immunovant
(IMVT)
|
0.4 |
$4.8M |
|
300k |
16.12 |
|
Omeros Corp Note 9.500% 6/1 (Principal)
|
0.4 |
$4.7M |
|
5.5M |
0.85 |
|
Revolution Medicines
(RVMD)
|
0.4 |
$4.7M |
|
100k |
46.70 |
|
Omeros Corporation Put Option
(OMER)
|
0.4 |
$4.6M |
|
1.1M |
4.10 |
|
Vaxcyte
(PCVX)
|
0.4 |
$4.5M |
|
125k |
36.02 |
|
Newamsterdam Pharma Company *w Exp 99/99/999
(NAMSW)
|
0.4 |
$4.2M |
|
245k |
17.11 |
|
Celcuity Note 2.750% 8/0 (Principal)
|
0.3 |
$4.0M |
|
3.0M |
1.33 |
|
Perceptive Cap Solutions Cor Cl A Ord Shs
(PCSC)
|
0.3 |
$3.8M |
|
350k |
10.73 |
|
Inspire Med Sys
(INSP)
|
0.3 |
$3.7M |
|
50k |
74.20 |
|
Ovid Therapeutics
(OVID)
|
0.3 |
$3.4M |
|
2.7M |
1.30 |
|
Bridgebio Pharma
(BBIO)
|
0.3 |
$3.4M |
|
65k |
51.94 |
|
Jazz Pharmaceuticals Shs Usd
(JAZZ)
|
0.3 |
$3.3M |
|
25k |
131.80 |
|
Crinetics Pharmaceuticals In
(CRNX)
|
0.3 |
$3.1M |
|
75k |
41.65 |
|
Mbx Biosciences
(MBX)
|
0.3 |
$2.9M |
|
165k |
17.50 |
|
Autolus Therapeutics Spon Ads
(AUTL)
|
0.2 |
$2.9M |
|
1.8M |
1.63 |
|
Ocular Therapeutix
(OCUL)
|
0.2 |
$2.8M |
|
239k |
11.69 |
|
Oaktree Acquisition Corp Iii Unit 10/04/2029
(OACCU)
|
0.2 |
$2.7M |
|
250k |
10.64 |
|
Eliem Therapeutics
(CLYM)
|
0.2 |
$2.6M |
|
1.3M |
2.01 |
|
Sagimet Biosciences Com Ser A
(SGMT)
|
0.2 |
$2.4M |
|
350k |
6.86 |
|
Astria Therapeutics
(ATXS)
|
0.2 |
$2.2M |
|
300k |
7.28 |
|
United Therapeutics Corporation
(UTHR)
|
0.2 |
$2.1M |
|
5.0k |
419.21 |
|
Geron Corporation
(GERN)
|
0.2 |
$2.1M |
|
1.5M |
1.37 |
|
Anteris Technologies Global
(AVR)
|
0.2 |
$2.0M |
|
450k |
4.50 |
|
Health Sciences Acq Corp 2
(OBIO)
|
0.2 |
$1.8M |
|
727k |
2.48 |
|
Eupraxia Pharmaceuticals
(EPRX)
|
0.2 |
$1.8M |
|
300k |
5.90 |
|
Cullinan Oncology
(CGEM)
|
0.1 |
$1.6M |
|
264k |
5.93 |
|
Atyr Pharma Com New Put Option
(ATYR)
|
0.1 |
$1.5M |
|
2.1M |
0.72 |
|
Milestone Pharmaceuticals
(MIST)
|
0.1 |
$1.3M |
|
667k |
2.00 |
|
Compass Pathways Sponsored Ads
(CMPS)
|
0.1 |
$1.1M |
|
200k |
5.73 |
|
Nextcure Com New
|
0.1 |
$1.1M |
|
192k |
5.86 |
|
Karyopharm Therapeutics Com New Call Option
(KPTI)
|
0.1 |
$1.0M |
|
158k |
6.54 |
|
Perspective Therapeutics Com New
(CATX)
|
0.1 |
$1.0M |
|
300k |
3.43 |
|
Arbutus Biopharma Call Option
(ABUS)
|
0.1 |
$960k |
|
212k |
4.54 |
|
Sutro Biopharma
(STRO)
|
0.1 |
$654k |
|
753k |
0.87 |
|
Jade Biosciences Com New
(JBIO)
|
0.0 |
$564k |
|
65k |
8.63 |
|
Engene Holdings
(ENGN)
|
0.0 |
$526k |
|
77k |
6.83 |
|
Context Therapeutics
(CNTX)
|
0.0 |
$390k |
|
403k |
0.97 |
|
Repare Therapeutics Ord
(RPTX)
|
0.0 |
$352k |
|
200k |
1.76 |
|
Crescent Biopharma
(CBIO)
|
0.0 |
$214k |
|
18k |
11.89 |
|
Adagio Med Hldgs
(ADGM)
|
0.0 |
$155k |
|
80k |
1.94 |
|
Q32 Bio
(QTTB)
|
0.0 |
$55k |
|
28k |
1.98 |
|
Silverback Therapeutics
(SPRY)
|
0.0 |
$25k |
|
2.5k |
10.05 |
|
Rocket Pharmaceuticals *w Exp 09/02/202
(RCKTW)
|
0.0 |
$3.0k |
|
75k |
0.04 |